10 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
, Biological, Radiological and Nuclear Medical Countermeasures.
On August 30, Nature published in vivo research findings that showed the role effector
8-K
VIR
Vir Biotechnology Inc
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
and Nuclear medical countermeasures of BARDA, which will support the discovery of new mAbs against a second pathogen of pandemic potential
8-K
EX-99.1
c5t3upns
4 Oct 22
Vir Biotechnology Awarded U.S. Government Contract to Support Pandemic Preparedness for Influenza and Other Infectious Disease Threats
8:23am
S-3ASR
EX-4.6
ifog9azk eg
10 Nov 20
Automatic shelf registration
5:13pm
- Prev
- 1
- Next